An Entity of Type: Public, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org:8891

Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.

Property Value
dbo:abstract
  • Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. (en)
dbo:assets
  • 1.456E8
dbo:foundingYear
  • 2004-01-01 (xsd:gYear)
dbo:industry
dbo:keyPerson
dbo:locationCity
dbo:numberOfEmployees
  • 152 (xsd:nonNegativeInteger)
dbo:thumbnail
dbo:type
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 48536390 (xsd:integer)
dbo:wikiPageLength
  • 8739 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1113856398 (xsd:integer)
dbo:wikiPageWikiLink
dbp:assets
  • 1.456E8
dbp:founded
  • 2004 (xsd:integer)
dbp:homepage
dbp:hqLocationCity
  • Schlieren, Zürich, Switzerland (en)
dbp:industry
dbp:keyPeople
  • Andreas Emmenegger, Chief Financial Officer (en)
  • Dr. Michael Stumpp, Chief Operating Officer (en)
  • Dr. Nicolas Leupin, Chief Medical Officer (en)
  • Dr. Patrick Amstutz, Chief Executive Officer (en)
  • William M. Burns, Chairman of the Board (en)
dbp:logo
  • Molecular_Partners_Logo.jpg (en)
dbp:name
  • Molecular Partners AG (en)
dbp:numEmployees
  • 152 (xsd:integer)
dbp:tradedAs
  • NASDAQ:MOLN (en)
dbp:type
dbp:wikiPageUsesTemplate
dcterms:subject
gold:hypernym
rdf:type
rdfs:comment
  • Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development. (en)
rdfs:label
  • Molecular Partners (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:homepage
foaf:isPrimaryTopicOf
foaf:name
  • Molecular Partners AG (en)
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License